Clinical Trial Update: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating bendamustine in combination with ofatumumab, carboplatin, and etoposide in non-Hodgkin lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Non-Hodgkin's Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-24